These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
293 related items for PubMed ID: 31728833
1. Novel exosomal miR-46146 transfer oxaliplatin chemoresistance in colorectal cancer. Xu Y, Zhu M. Clin Transl Oncol; 2020 Jul; 22(7):1105-1116. PubMed ID: 31728833 [Abstract] [Full Text] [Related]
2. Exosomal miR-208b related with oxaliplatin resistance promotes Treg expansion in colorectal cancer. Ning T, Li J, He Y, Zhang H, Wang X, Deng T, Liu R, Li H, Bai M, Fan Q, Zhu K, Ying G, Ba Y. Mol Ther; 2021 Sep 01; 29(9):2723-2736. PubMed ID: 33905821 [Abstract] [Full Text] [Related]
3. Exosome-transmitted miR-128-3p increase chemosensitivity of oxaliplatin-resistant colorectal cancer. Liu T, Zhang X, Du L, Wang Y, Liu X, Tian H, Wang L, Li P, Zhao Y, Duan W, Xie Y, Sun Z, Wang C. Mol Cancer; 2019 Mar 19; 18(1):43. PubMed ID: 30890168 [Abstract] [Full Text] [Related]
9. MiR-483-3p regulates oxaliplatin resistance by targeting FAM171B in human colorectal cancer cells. Liang H, Xu Y, Zhang Q, Yang Y, Mou Y, Gao Y, Chen R, Chen C, Dai P. Artif Cells Nanomed Biotechnol; 2019 Dec 19; 47(1):725-736. PubMed ID: 30861353 [Abstract] [Full Text] [Related]
13. Cancer-associated fibroblast exosome LINC00355 promotes epithelial-mesenchymal transition and chemoresistance in colorectal cancer through the miR-34b-5p/CRKL axis. Hu JH, Tang HN, Wang YH. Cancer Gene Ther; 2024 Feb 19; 31(2):259-272. PubMed ID: 38052858 [Abstract] [Full Text] [Related]
14. Exosome-delivered circRNA promotes glycolysis to induce chemoresistance through the miR-122-PKM2 axis in colorectal cancer. Wang X, Zhang H, Yang H, Bai M, Ning T, Deng T, Liu R, Fan Q, Zhu K, Li J, Zhan Y, Ying G, Ba Y. Mol Oncol; 2020 Mar 19; 14(3):539-555. PubMed ID: 31901148 [Abstract] [Full Text] [Related]
15. Identification of key lncRNAs associated with oxaliplatin resistance in colorectal cancer cells and isolated exosomes: From In-Silico prediction to In-Vitro validation. Sahebnasagh R, Deli H, Shadboorestan A, Vakili-Ghartavol Z, Salehi N, Komeili-Movahhed T, Azizi Z, Ghahremani MH. PLoS One; 2024 Mar 19; 19(10):e0311680. PubMed ID: 39401197 [Abstract] [Full Text] [Related]
16. Overexpression of MEG3 sensitizes colorectal cancer cells to oxaliplatin through regulation of miR-141/PDCD4 axis. Wang H, Li H, Zhang L, Yang D. Biomed Pharmacother; 2018 Oct 19; 106():1607-1615. PubMed ID: 30119236 [Abstract] [Full Text] [Related]
19. Exosomes from drug-resistant breast cancer cells transmit chemoresistance by a horizontal transfer of microRNAs. Chen WX, Liu XM, Lv MM, Chen L, Zhao JH, Zhong SL, Ji MH, Hu Q, Luo Z, Wu JZ, Tang JH. PLoS One; 2014 Oct 19; 9(4):e95240. PubMed ID: 24740415 [Abstract] [Full Text] [Related]
20. miR-193a-5p as a promising therapeutic candidate in colorectal cancer by reducing 5-FU and Oxaliplatin chemoresistance by targeting CXCR4. Azar MRMH, Aghazadeh H, Mohammed HN, Sara MRS, Hosseini A, Shomali N, Tamjidifar R, Tarzi S, Mansouri M, Sarand SP, Marofi F, Akbari M, Xu H, Shotorbani SS. Int Immunopharmacol; 2021 Mar 19; 92():107355. PubMed ID: 33429333 [Abstract] [Full Text] [Related] Page: [Next] [New Search]